Perrigo Co PLC (PRGO)
53.35
+0.72 +1.37%
NYSE
Aug 14, 12:28
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 5.074B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 1.74 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 240.20M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 35.66% |
| Profit Margin (Quarterly) | 4.97% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 1.63% |
| Price and Valuation | |
| Market Cap | 7.281B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 1.442 |
| PE Ratio | 30.66 |
| Price to Book Value | 1.232 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.7009 |
| Free Cash Flow (Quarterly) | 264.60M |
| Return on Equity | Upgrade |
View All PRGO News
News
-
WireHeadlineTime (ET)
-
SA Breaking News08/11 15:32
-
MT Newswires08/11 09:56
-
PR Newswire08/11 09:29
-
MT Newswires08/06 07:58
-
Globe Newswire08/06 07:08
-
MT Newswires08/05 17:25
-
MT Newswires08/05 16:37
-
Yahoo08/05 12:37
-
SA Breaking News08/05 10:55
-
MT Newswires08/05 10:00
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 11/06/2020 08:00 EST | Misc | Perrigo Co PLC Third Quarter Earnings Conference Call for 2020 |
| 11/06/2020 | Earnings | Perrigo Co PLC Third Quarter Earnings for 2020 Release |
| 08/05/2020 09:00 EDT | Misc | Perrigo Co PLC Second Quarter Earnings Conference Call for 2020 |
| 08/05/2020 | Earnings | Perrigo Co PLC Second Quarter Earnings Result for 2020 |
| 05/28/2020 | Dividends | Amount: 0.225, Declared Date: May 05 2020, Pay Date: Jun 16 2020 |
| 05/06/2020 11:30 IST | Misc | Perrigo Co PLC Annual General Meeting for 2019 |
| 04/30/2020 08:30 EDT | Misc | Perrigo Co PLC First Quarter Earnings Conference Call for 2020 |
| 04/30/2020 | Earnings | Perrigo Co PLC First Quarter Earnings Result for 2020 |
| 02/27/2020 08:30 EST | Misc | Perrigo Co PLC Fourth Quarter Earnings Conference Call for 2019 |
| 02/27/2020 | Earnings | Perrigo Co PLC Fourth Quarter Earnings Results for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.perrigo.com
- Investor Relations URL: http://perrigo.investorroom.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Equity Style: Mid Cap/Value
- Next Earnings Release: Nov. 06, 2020
- Last Earnings Release: Aug. 05, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: May. 28, 2020
- Description: Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to over the counter and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 53.35 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| XPH | SPDR® S&P Pharmaceuticals ETF | 4.34% |
| SSHVX | Sound Shore Institutional | 4.26% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 3.69% |
| TMCJX | Touchstone Mid Cap C | 3.60% |
| IHE | iShares US Pharmaceuticals ETF | 3.12% |
| PPH | VanEck Vectors Pharmaceutical ETF | 2.68% |
| PJP | Invesco Dynamic Pharmaceuticals ETF | 2.55% |
| RRMVX | T. Rowe Price Mid-Cap Value R | 2.16% |
| JMVNX | JHFunds2 Mid Value NAV | 1.82% |
| GRX | Gabelli Health & Wellness | 1.63% |
| VASVX | Vanguard Selected Value Inv | 1.15% |
| DFTVX | DFA US Targeted Value R1 | 0.47% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- PRGO Tweets Stocktwits
Advertisement
